TMS for Treatment-Resistant Depression
When depression does not improve after one or more medications, it can feel discouraging. Understanding TMS for treatment-resistant depression can give you a clearer objective and renewed confidence as you plan the next steps with your care team.
At Desert View Counseling, we use NeuroStar systems to deliver non-invasive magnetic pulses to mood-related brain circuits. We explain the evidence, outline timelines, and build a plan that respects your preferences and daily routine.
What Treatment-Resistant Means—and Why Circuits Matter
Treatment-resistant depression usually refers to symptoms that persist despite trying one or more antidepressants at adequate doses and durations. Medication acts throughout the body, but depression also involves patterns within brain networks that regulate motivation, focus, and emotion. NeuroStar TMS delivers targeted magnetic pulses to the scalp, directly engaging the circuits affected by treatment-resistant depression, all while you remain awake. Over repeated sessions, this stimulation can support brain plasticity, helping circuits communicate more effectively.
How NeuroStar TMS Fits Into Care
We deliver a standard course of NeuroStar TMS therapy for medication-resistant depression over about seven weeks. No anesthesia is required, and there is no exposure to systemic medication.
The risk of side effects is moderate and most often includes temporary scalp discomfort or a mild headache around session times. We plan your treatment schedule, ensure you are comfortable, and use validated mood scales so you can see your progress as it develops.
NeuroStar is the #1 physician-recommended TMS brand and is FDA-cleared for major depressive disorder (MDD) in adults. At our practice, patients aged 15 and up may be considered for MDD candidacy after evaluation.
What the Evidence Shows for People Who Have Tried Medications
Real-world data helps set expectations for TMS patients with previous medication attempts that failed to alleviate depression. In a large outcomes registry, 83 percent of patients experienced improvement with NeuroStar TMS treatment, reflecting meaningful symptom change across diverse clinics and patient profiles (Sackeim HA et al., 2020). J Affective Disorders, 277(12):65-74). Results commonly build across four to six weeks, and benefits can last up to 12 months, which is why we schedule structured follow-up and check-ins after the series (Dunner DL et al., 2014). J Clin Psychiatry, 75(12):1394-1401).
Research on medication sequences (STAR*D) also suggests that, with each additional drug trial, remission becomes less likely and discontinuation more common due to side effects, which is part of why we discuss a device-based option in your care planning (Results from the STAR*D study, medication attempts (n=4,041), Trivedi (2006), Am J Psychiatry | Rush (2006), Am J Psychiatry | Fava (2006), Am J Psychiatry | McGrath (2006), Am J Psychiatry).
What You Can Expect During and After TMS Treatment
Before your NeuroStar TMS treatment starts for depression that is resistant to medication, we review your history, goals, and prior treatments to confirm candidacy and personalize the approach. During the treatment series, you remain awake and can return to your usual activities afterward. Many people notice changes in energy, concentration, or sleep before mood shifts become clear—signs that circuit-level change may be underway.
At the end of the series, we summarize your scores, discuss your experience, and create a follow-up plan. If symptoms recur later, we can discuss retreatment with NeuroStar TMS based on your prior response and preferences.
Contact Us About TMS Therapy for Treatment-Resistant Depression
If medications have not brought the relief you want, TMS for treatment-resistant depression may be an option to consider as part of a thoughtful, evidence-informed plan. Contact us at Desert View Counseling to schedule a conversation and explore whether NeuroStar TMS fits your goals.
